Quick Answer
BioScience Health Innovations, Inc. reported Total Assets of $1.71 million for the year ending 2025.
- BioScience Health Innovations, Inc. showed an increase of +95.4% in Total Assets from 2024 to 2025.
- This data is from BioScience Health Innovations, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2019: $8.0 thousand | Q1 2020: $7.9 thousand | Q2 2020: $22.9 thousand | Q4 2020: $20.1 thousand | Q1 2021: $2.4 thousand | Q2 2021: $374.00 | Q4 2021: $96.1 thousand | Q1 2022: $71.1 thousand | Q2 2022: $24.5 thousand | Q3 2022: $16.3 thousand | Q4 2022: $28.3 thousand | Q1 2023: $8.8 thousand | Q1 2023: $27.4 thousand | Q2 2023: $63.0 thousand | Q3 2023: $95.0 thousand | Q1 2024: $154.8 thousand | Q2 2024: $213.6 thousand | Q3 2024: $415.8 thousand | Q1 2025: $1.39 million | Q2 2025: $2.06 million | Q3 2025: $2.07 million.
- Over the full 8 years of available data (2019 to 2025), BioScience Health Innovations, Inc.'s Total Assets has grown by 89,751.6%.
- Historical annual values: Fiscal year 2025: $1.71 million | Fiscal year 2024: $873.8 thousand | Fiscal year 2023: $93.4 thousand | Fiscal year 2022: $31.6 thousand | Fiscal year 2022: $16.3 thousand | Fiscal year 2021: $6.3 thousand | Fiscal year 2020: $20.6 thousand | Fiscal year 2019: $1.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: